We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia
News

Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia

Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia
News

Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Emergent BioSolutions and Ninebio Sdn. Bhd. Announce Joint Venture in Malaysia"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Emergent BioSolutions and Ninebio Sdn. Bhd. (9Bio) have announced the formation of a joint venture in Malaysia that will focus on creating critical biologics infrastructure and supplying biodefense countermeasures, including BioThrax® (Anthrax Vaccine Adsorbed), and other medical and complementary products and services to the Government of Malaysia.

It is anticipated that the joint venture will also supply such products and services to certain member countries of the Organization of the Islamic Conference ("OIC") and other countries within Asia.

9Bio is a Malaysian Government owned company and one of the National Institutes of Health under the Ministry of Health. 9Bio is fully funded by the Government of Malaysia. The Government of Malaysia, through 9Bio, has selected Emergent BioSolutions as one of its principal partners to assist, as a contract service provider, in building vaccine development and manufacturing infrastructure. The joint venture will be majority owned by Emergent BioSolutions.

Witnessing the signing ceremony, Director General of the Malaysian Ministry of Health, Tan Sri Datuk Dr Haji Ismail Merican affirmed that through 9Bio, one of the National Institutes of Health in Malaysia, the Ministry of Health would be able to focus on developing and manufacturing biologics, biosecurity and bioterrorism countermeasures for Malaysia.

Advertisement